Allergy Therapeutics plc (LON:AGY - Get Free Report)'s share price reached a new 52-week high on Tuesday . The stock traded as high as GBX 8.50 ($0.11) and last traded at GBX 7.50 ($0.10), with a volume of 666418 shares changing hands. The stock had previously closed at GBX 8 ($0.11).
Allergy Therapeutics Price Performance
The stock has a market cap of £393.21 million, a PE ratio of -7.71, a P/E/G ratio of -30.70 and a beta of 1.40. The business has a fifty day simple moving average of GBX 7.48 and a two-hundred day simple moving average of GBX 6.90. The company has a current ratio of 1.63, a quick ratio of 1.48 and a debt-to-equity ratio of 835.48.
Allergy Therapeutics Company Profile
(
Get Free Report)
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Read More
Before you consider Allergy Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allergy Therapeutics wasn't on the list.
While Allergy Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
